Corcept director granted 12,500 stock options
Corcept Therapeutics director Leonard G. Baker Jr received a grant of stock options covering 12,500 shares of common stock on May 21, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Corcept Therapeutics director Leonard G. Baker Jr received a grant of stock options covering 12,500 shares of common stock on May 21, 2026. The options have an exercise price of $59.69 per share and expire on May 21, 2036. They vest in equal monthly installments over one year starting on the monthly anniversary of May 21, 2026, contingent on his continued service, and represent equity-based compensation rather than an open-market trade.
Insider Trade Summary
Grant/Award: 12,500 shares
Grant/Award
1 txn
Insider
BAKER G LEONARD JR
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right To Buy) | 12,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right To Buy) — 12,500 contracts (Direct)
Footnotes (1)
- F1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Key Figures
Options granted: 12,500 options
Exercise price: $59.69 per share
Underlying shares: 12,500 shares
+3 more
6 metrics
Options granted
12,500 options
Stock Option (Right To Buy) grant to director
Exercise price
$59.69 per share
Conversion or exercise price of option grant
Underlying shares
12,500 shares
Common stock underlying the options
Grant date
May 21, 2026
Transaction date for option award
Expiration date
May 21, 2036
Option term end for this grant
Vesting schedule
Monthly over one year
From monthly anniversary of May 21, 2026, subject to service
Key Terms
Stock Option (Right To Buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more
5 terms
Stock Option (Right To Buy) financial
"security_title: Stock Option (Right To Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 59.6900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-21T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CORCEPT THERAPEUTICS INC (CORT) report for Leonard G. Baker Jr?
Corcept Therapeutics reported that director Leonard G. Baker Jr received a grant of 12,500 stock options. These options give him the right to buy common shares at a fixed exercise price as part of his equity compensation package.
What is the exercise price of Leonard G. Baker Jr’s new Corcept (CORT) stock options?
The granted stock options have an exercise price of $59.69 per share. This is the fixed price at which Baker can purchase Corcept common stock if and when he exercises the options in the future.
When do Leonard G. Baker Jr’s Corcept (CORT) options vest and become exercisable?
The options vest in equal monthly installments over one year starting on the monthly anniversary of May 21, 2026. Vesting is conditioned on Baker’s continued service with Corcept on each monthly vesting date, according to the footnote.
What is the expiration date of Leonard G. Baker Jr’s Corcept (CORT) stock options?
The options expire on May 21, 2036. After that expiration date, any unexercised portion of the 12,500 options will no longer be usable, so exercise must occur before that deadline if they are vested.
Does Leonard G. Baker Jr’s Form 4 for Corcept (CORT) show a stock purchase or sale?
The Form 4 reflects a grant of stock options classified as an acquisition under code A, not an open-market purchase or sale. It represents compensation awarded by the company rather than a discretionary trade in Corcept shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
